Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Amino Acids and Derivatives >  Leucine derivatives >  BOC-L-NORLEUCINE

BOC-L-NORLEUCINE

Basic information Safety Supplier Related

BOC-L-NORLEUCINE Basic information

Product Name:
BOC-L-NORLEUCINE
Synonyms:
  • (S)-2-((tert-Butoxycarbonyl)aMino)hexanoic acid
  • N-[(1,1-Dimethylethoxy)carbonyl]-L-norleucine
  • BOC-L-Norleucine,98%
  • N-Boc-L-Norleucine (Dry wt.), May Cont. up to ca 10% Solvent
  • Norleucine, N-carboxy-, N-tert-butyl ester
  • (Tert-Butoxy)Carbonyl Nle-OH (Syrup)
  • Boc-(S)-2-aminohexanoicacid
  • BOC-L-NORLEUCINE
CAS:
6404-28-0
MF:
C11H21NO4
MW:
231.29
Product Categories:
  • Amino Acids
Mol File:
6404-28-0.mol
More
Less

BOC-L-NORLEUCINE Chemical Properties

Boiling point:
373.37°C (rough estimate)
Density 
1.1202 (rough estimate)
refractive index 
1.4425
storage temp. 
Keep in dark place,Sealed in dry,Room Temperature
solubility 
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
form 
Powder
pka
4.02±0.21(Predicted)
color 
Colorless to light yellow
optical activity
[α]20/D 8±1°, c = 1% in methanol
BRN 
3608376
CAS DataBase Reference
6404-28-0(CAS DataBase Reference)
More
Less

Safety Information

Safety Statements 
24/25
WGK Germany 
3
HS Code 
29224985

MSDS

More
Less

BOC-L-NORLEUCINE Usage And Synthesis

Uses

A boc protected amino acid derivative

reaction suitability

reaction type: Boc solid-phase peptide synthesis

Synthesis

327-57-1

24424-99-5

6404-28-0

The general procedure for the synthesis of N-BOC-L-norleucine from L-norleucine and di-tert-butyl dicarbonate was as follows: free L-norleucine (400 mg, 3.05 mmol) was dissolved in a solvent mixture of water and THF (8.8 mL:8.8 mL), NaHCO3 (768 mg, 9.15 mmol) was added and di-tert-butyl dicarbonate ( 800 mg, 3.66 mmol). The reaction mixture was stirred at 0 °C for 30 min, then gradually warmed to room temperature and continued to stir overnight. Upon completion of the reaction, water (10 mL) was added to dissolve any precipitate that may have formed. Unreacted di-tert-butyl dicarbonate was removed by three extractions with petroleum ether. N-BOC-L-norleucine in the aqueous phase was acidified to pH ≈ 3 with 1 M NaHSO4 solution and subsequently extracted three times with EtOAc. The organic layers were combined and dried with Na2SO4. The solvent was removed by concentration under reduced pressure to give the clear oily product N-BOC-L-norleucine (573 mg, 81% yield). The product was characterized by 1H NMR (400 MHz, DMSO-d6): δ 12.38 (bs, 1H, COOH), 7.02 (d, J=8.2 Hz, 1H, NH), 3.87-3.78 (m, 1H, CH), 1.69-1.47 (m, 2H, CH2), 1.37 (s, 9H, t-Bu), 1.32- 1.20 (m, 4H, CH2), 0.85 (t, J=7.0Hz, 3H, CH3).

References

[1] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 21, p. 6891 - 6899
[2] Bioorganic and medicinal chemistry letters, 2004, vol. 14, # 1, p. 275 - 278

BOC-L-NORLEUCINESupplier

Taizhou Tianhong Biochemistry Technology Co., Ltd. Gold
Tel
0523-86132544 15366717810
Email
sales@thbiochem.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
4006356688 18621169109
Email
market03@meryer.com
Alfa Aesar
Tel
400-6106006
Email
saleschina@alfa-asia.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com